Effects of Liraglutide and Testosterone Replacement Therapy on Features of Hypogonadism and Weight Loss in Obese Men With Persistent Features of Hypogonadism.

Registration

Registration

NCT03619330

Study type

INTERVENTIONAL

Allocation

RANDOMIZED

Phase

PHASE4

Masking

NONE

Status

COMPLETED

Enrollment

30

Start

2014-12

Primary completion

2015-08

Lead sponsor

University Medical Centre Ljubljana

Conditions

Hypogonadism; Obesity

Interventions

DRUG:liraglutide; DRUG:Testosterone

Results posted

FALSE

Registered primary outcomes

• The main outcome was improvements of symptoms related to hypogonadism [Patients were screened and asked for symptoms at the beginning and every 4 weeks for 16 weeks of the study.]
• The main outcome was change testosterone level. [Patient's blood was drawn at the base point and every four weeks during 16 weeks of clinical trial.]
• the main outcome was change in gonadotropin levels. [Patient's blood was drawn at the base point and every four weeks during 16 weeks of clinical trial.]